MODULAR MEDICAL, INC. — Operating Income by Fiscal Year
15 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/e2b9e18d-74a7-4789-9681-3b3d3c14a818/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-27.6M | 2025-04-01 – 2026-03-31 | evidence 0001213900-26-073223 |
| FY 2024 | $-19.0M | 2024-04-01 – 2025-03-31 | evidence 0001213900-25-055793 |
| FY 2023 | $-17.5M | 2023-04-01 – 2024-03-31 | evidence 0001213900-24-054877 |
| FY 2022 | $-13.9M | 2022-04-01 – 2023-03-31 | evidence 0001213900-24-054877 |
| FY 2021 | $-14.9M | 2021-04-01 – 2022-03-31 | evidence 0001019056-22-000478 |
| FY 2020 | $-7.3M | 2020-04-01 – 2021-03-31 | evidence 0001019056-21-000387 |
| FY 2019 | $-5.3M | 2019-04-01 – 2020-03-31 | evidence 0001019056-20-000388 |
| FY 2018 | $-2.6M | 2018-04-01 – 2019-03-31 | evidence 0001019056-19-000385 |
| FY 2017 | $-666.2k | 2017-04-01 – 2018-03-31 | evidence 0001019056-18-000822 |
| FY 2016 | $-29.4k | 2016-04-01 – 2017-03-31 | evidence 0001019056-18-000822 |
| FY 2015 | $-16.1k | 2014-07-01 – 2015-06-30 | evidence 0001548123-15-000354 |
| FY 2014 | $-185.9k | 1998-10-22 – 2014-06-30 | evidence 0001548123-14-000377 |
| FY 2013 | $-184.2k | 1998-10-22 – 2014-03-31 | evidence 0001548123-14-000193 |
| FY 2012 | $-173.1k | 1998-10-22 – 2013-03-31 | evidence 0001549632-13-000017 |
| FY 2011 | $-162.8k | 1998-10-22 – 2012-03-31 | evidence 0001549632-12-000006 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).